Stocktoria
Xeris Biopharma Holdings, Inc. XERS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-06-21
Xeris Biopharma Holdings, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| D. E. Shaw & Co., Inc. | 7,788,811 | $45.2M |
| BlackRock Finance, Inc. | 10,332,078 | $23.2M |
| MILLENNIUM MANAGEMENT LLC | 2,265,974 | $13.1M |
| TWO SIGMA INVESTMENTS, LP | 1,924,202 | $11.2M |
| AQR CAPITAL MANAGEMENT LLC | 1,394,376 | $8.1M |
| CITADEL ADVISORS LLC | 747,234 | $4.3M |
| RENAISSANCE TECHNOLOGIES LLC | 452,860 | $2.6M |
Source: SEC EDGAR filings · CIK 0001867096 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.